Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ALZN Alzamend Neuro Inc

Price (delayed)

$0.6581

Market cap

$4.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.04

Enterprise value

$983,684

Highlights
ALZN's EPS has soared by 84% year-on-year and by 54% since the previous quarter
ALZN's net income has soared by 66% year-on-year and by 28% since the previous quarter
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter

Key stats

What are the main financial stats of ALZN
Market
Shares outstanding
6.6M
Market cap
$4.34M
Enterprise value
$983,684
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.04
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$4.21M
Net income
-$4.23M
EBIT
-$4.21M
EBITDA
-$4.16M
Free cash flow
-$7.4M
Per share
EPS
-$3.04
EPS diluted
-$3.04
Free cash flow per share
-$1.34
Book value per share
$0.63
Revenue per share
$0
TBVPS
$0.76
Balance sheet
Total assets
$4.18M
Total liabilities
$725,851
Debt
$0
Equity
$3.45M
Working capital
$3.22M
Liquidity
Debt to equity
0
Current ratio
5.44
Quick ratio
4.63
Net debt/EBITDA
0.81
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-149.1%
Return on equity
-504.2%
Return on invested capital
N/A
Return on capital employed
-122%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALZN stock price

How has the Alzamend Neuro stock price performed over time
Intraday
21.87%
1 week
-1.78%
1 month
-17.22%
1 year
-88.85%
YTD
-43.27%
QTD
-30.6%

Financial performance

How have Alzamend Neuro's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$4.21M
Net income
-$4.23M
Gross margin
N/A
Net margin
N/A
ALZN's operating income has surged by 66% year-on-year and by 28% since the previous quarter
ALZN's net income has soared by 66% year-on-year and by 28% since the previous quarter

Price vs fundamentals

How does ALZN's price correlate with its fundamentals

Growth

What is Alzamend Neuro's growth rate over time

Valuation

What is Alzamend Neuro stock price valuation
P/E
N/A
P/B
1.04
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALZN's EPS has soared by 84% year-on-year and by 54% since the previous quarter
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter

Efficiency

How efficient is Alzamend Neuro business performance
ALZN's ROA has soared by 69% YoY and by 49% from the previous quarter

Dividends

What is ALZN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALZN.

Financial health

How did Alzamend Neuro financials performed over time
The company's total liabilities has shrunk by 84% YoY and by 42% QoQ
The current ratio has grown by 43% from the previous quarter
ALZN's debt is 100% smaller than its equity
ALZN's equity has surged by 181% year-on-year but it is down by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.